Pharmaceuticals & Biotech

From Primary Care to Aesthetic Care: WaltCare Clinic’s Holistic Holiday Health Package

From Primary Care to Aesthetic Care WaltCare Clinic launches its Holistic Holiday Health Package, combining primary care check-ups with aesthetic treatments such as Endolaser, body contouring, and cellulite therapy. The offer promotes complete health and beauty care in one place, … Continue reading →

Navigating DPDP Act: A Business Guide to India’s New Data Protection Law

The DPDP Act marks a fundamental shift in how India governs digital personal data. With businesses increasingly relying on data-driven decision-making, a structured legal framework became inevitable. The introduction of the Digital Personal Data Protection Act is not just about … Continue reading →

How Certinal Helps Hospitals Align with DPDP – Securely, Seamlessly, and Patient-First

DPDP is here. Learn how Certinal helps hospitals embed privacy, track consent, and stay compliant with India’s new data protection law. India’s Digital Personal Data Protection (DPDP) Act, 2023 is now in force, turning patient data into a regulated asset. … Continue reading →

MeAgain Ranked the #1 GLP-1 Tracking App for 2026

Screenshot of MeAgain GLP-1 tracking app. MeAgain Named the #1 GLP-1 Tracking App for Zepbound, Mounjaro, Wegovy & Ozempic Users in 2026. Comprehensive all-in-one platform outperforms five major competitors for injection tracking, nutrition support, side-effect monitoring, and progress visualization NEW … Continue reading →

Brutons Tyrosine Kinase Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Brutons Tyrosine Kinase Inhibitors Pipeline Insight 2025” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Brutons Tyrosine Kinase Inhibitors pipeline landscape. It covers the Brutons Tyrosine Kinase Inhibitors pipeline drug profiles, including clinical and … Continue reading →

Muscle Spasticity Clinical Trial Pipeline Gains Momentum: 15+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Muscle Spasticity Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Muscle Spasticity pipeline landscape. It covers the Muscle Spasticity pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Beta Thalassemia Pipeline Outlook Report 2025: Promising Drugs and MOA Innovations Reshape Future Treatment Approaches | DelveInsight

DelveInsight’s “Beta Thalassemia Pipeline Insight 2025” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in the Beta Thalassemia pipeline landscape. It covers the Beta Thalassemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Follicular Lymphoma Clinical Trial Pipeline Shows Potential with Active Contributions from 45+ Key Companies | DelveInsight

DelveInsight’s, “Follicular Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Thyroid Cancer Clinical Trial Pipeline Expands as 50+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Thyroid Cancer Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 51+ pipeline drugs in Thyroid Cancer pipeline landscape. It covers the Thyroid Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Acute Lymphocytic Leukemia Pipeline Drugs Insights Report 2025: Promising Drugs and MOA Innovations Reshape Future Treatment Approaches | DelveInsight

DelveInsight’s, “Acute Lymphocytic Leukemia Pipeline Insight 2025” report provides comprehensive insights about 120+ companies and 125+ pipeline drugs in the Acute Lymphocytic Leukemia pipeline landscape. It covers the Acute Lymphocytic Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Tuesday - December 09, 2025

Category Archives: Pharmaceuticals & Biotech